Norgine

Scotland flag
#Chemotherapy #Hearing Loss #NHS Scotland #Norgine #Scottish Medicines Consortium (SMC)

SMC okays Pedmarqsi to prevent cisplatin-induced hearing loss

Pedmarqsi (sodium thiosulfate solution for infusion) has become the first treatment to be made available within NHS Scotland for the prevention of ototoxicity (hearing loss) induced by cisplatin chemotherapy in patients up to 18 years of age with localised, non-metastatic, solid tumours.  The decision follows that of… Read More

#News #Regulatory